Today: 24 April 2026
MakeMyTrip to Buy Flamingo Transworld Stake as India Holiday Package Travel Grows
6 March 2026
1 min read

MakeMyTrip to Buy Flamingo Transworld Stake as India Holiday Package Travel Grows

Gurugram, March 6, 2026, 20:19 IST

MakeMyTrip on Thursday announced an agreement to take a majority stake in Flamingo Transworld, a regional tour operator, marking another move into bundled holiday packages that combine hotels, transport, and sightseeing. No price was disclosed, and closing conditions still apply.

This is a notable shift: hotels and packages now top the revenue charts for MakeMyTrip, and they’re expanding at a pace that’s leaving air ticketing behind. For the quarter ending Dec. 31, that division booked a 9.7% jump in revenue, reaching $161.4 million. Air ticketing, on the other hand, slid 2.1%. The company blamed it on tight domestic airline supply and a softer rupee.

Revenue for the quarter climbed 10.6% to $295.7 million. Gross bookings hit $2.78 billion, reflecting the total value of travel sold across the company’s platforms. That shift is part of the reason the company is chasing bigger exposure in package tours now, rather than holding out for a rebound in flight growth.

For nearly three decades, Flamingo has carved out its presence across Gujarat, Maharashtra, Rajasthan, and Madhya Pradesh. The company pushes its domestic and international group tours mostly via 51 offices—an offline setup that hands MakeMyTrip a stronger grip in regional markets.

Group CEO Rajesh Magow sees Flamingo as a strong match for MakeMyTrip’s packages growth push. Chief Operating Officer Mohit Kabra described it as “a profitable growth opportunity.” For Sanjay Shah, Flamingo’s co-founder, the partnership might be the key to creating a pan-India tour company.

This transaction adds to MakeMyTrip’s string of acquisitions, not a fresh direction. The company previously picked up Quest2Travel (corporate travel), Simplotel (hotel tech), BookMyForex (currency exchange), Savaari (intercity cars), and Happay (expense management), moves that have helped broaden its footprint in both leisure and business travel.

Competition is in the mix. Easy Trip Planners, a smaller competitor, has pushed to expand past just flights, while Yatra operates its own hotels-and-packages segment. Indian online travel players are all looking to carve out more of the country’s leisure spending.

Plenty remains unclear. The deal hasn’t closed yet, and MakeMyTrip is keeping mum on the price, only disclosing plans to take a majority stake. Meanwhile, marketing and sales promo spending jumped to $134.2 million in the first nine months of fiscal 2026, up from $123.2 million a year ago. Reported profit for the December quarter also slipped, coming in at $7.3 million—down sharply from $27.1 million.

Stock Market Today

  • Morgan Stanley $1000 Investment a Decade Ago Worth $3,775 Today
    April 24, 2026, 10:24 AM EDT. A $1,000 investment in Morgan Stanley (MS) stocks made in January 2015 would be worth $3,775.30 as of January 16, 2025, reflecting a 277.53% gain. Morgan Stanley, a leading financial services firm headquartered in New York, operates through three main segments: Institutional Securities, Wealth Management, and Investment Management. The Wealth Management segment accounts for nearly half of the company's 2023 revenue. Over the last decade, strategic acquisitions like E*Trade Financial and Eaton Vance bolstered its growth. These results highlight the potential of patient investing in diversified financial firms amid evolving market conditions.

Latest article

Organon Stock Jumps as Sun Pharma’s Reported $13 Billion Bid Puts OGN in Takeover Spotlight

Organon Stock Jumps as Sun Pharma’s Reported $13 Billion Bid Puts OGN in Takeover Spotlight

24 April 2026
Jersey City, New Jersey, April 24, 2026, 09:55 (EDT) Organon & Co. shares rose sharply Friday after The Economic Times reported that India’s Sun Pharmaceutical Industries had submitted a binding, all-cash offer of about $13 billion for the U.S. women’s health drugmaker, stepping up a takeover race that also includes EQT and Germany’s Grünenthal. The newspaper said the offer was backed by $12 billion in financing from JPMorgan, MUFG and Citi, and that Organon shareholders would not receive Sun Pharma stock. The move matters because the reported bid is far above Organon’s equity value and would put a debt-heavy former
Joby Aviation’s LA Air Taxi Bet Gets a Rooftop Test as Investors Watch Certification

Joby Aviation’s LA Air Taxi Bet Gets a Rooftop Test as Investors Watch Certification

24 April 2026
Reuben Brothers and Joby Aviation announced plans for an air-taxi vertiport at Park Elm Residences at Century Plaza in Los Angeles, using the South Tower’s helipad and adding charging and a passenger lounge. The project requires local, state, and federal approvals. Joby is still seeking commercial certification for its electric aircraft. Residents would be able to book flights within the Los Angeles area.
MaxLinear Stock Jumps 67% as AI Data-Center Demand Powers Outlook

MaxLinear Stock Jumps 67% as AI Data-Center Demand Powers Outlook

24 April 2026
MaxLinear shares jumped 67% to $57.30 in early Friday trading after first-quarter revenue rose 43% to $137.2 million, beating estimates. The company projected second-quarter revenue of $160 million to $170 million, citing strong demand for optical data-center chips used in AI infrastructure.
Robinhood Markets cuts RVI IPO size as premium card push targets wealthier investors
Previous Story

Robinhood Markets cuts RVI IPO size as premium card push targets wealthier investors

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Next Story

Stock Market Today 07.03.2026

Go toTop